A novel cytotoxicity screening assay using a multiwell fluorescence scanner

Anna Liisa Nieminen, Gregory James Gores, John M. Bond, Roberto Imberti, Brian Herman, John J. Lemasters

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

A new assay using a multiwell fluorescence scanner was developed for screening cytotoxicity to cells cultured in 96-well microtiter plates. The assay is based on binding of propidium iodide to nuclei of cells whose plasma membranes have become permeable due to cell death. Fluorescence of propidium iodide measured with a multiwell fluorescence scanner increased in proportion to the number of permeabilized cells. After ATP depletion of hepatocytes and neonatal cardiac myocytes with metabolic inhibitors ("chemical hypoxia"), and exposure of Madine Darby canine kidney cells to the toxic chemical, HgCl2, propidium iodide fluorescence progressively increased. Increases of fluorescence were linearly proportional with release of lactate dehydrogenase into the culture medium. Employing this cytotoxicity screening assay, protection by various agents against lethal injury was evaluated in cultured hepatocytes during chemical hypoxia. Inhibitors of cysteine proteases (i.e., antipain, leupeptin, E-64), serine proteases (i.e., PMSF), and aspartic acid proteases (i.e., pepstatin A) did not protect against chemical hypoxia. In contrast, 1,10-phenanthroline, an inhibitor of metalloprotease, markedly protected against the onset of cell death during chemical hypoxia. Half-maximal protection after 60 min occurred at 0.5 μm. Phospholipase inhibitors, chlorpromazine (50 μm) and mepacrine (50 μm), also substantially retarded cell killing. U74006F, an inhibitor of lipid peroxidation, slowed cell killing to a lesser extent during chemical hypoxia and after oxidative stress with t-butyl hydroperoxide. Calciphor, a dimer of prostaglandin B1, did not protect against cell killing during chemical hypoxia or t-butyl hydroperoxide toxicity. In conclusion, this high capacity cytotoxicity assay for cells cultured in 96-well microtiter plates is suitable for rapid screening of potential cytoprotective agents in a variety of cell types.

Original languageEnglish (US)
Pages (from-to)147-155
Number of pages9
JournalToxicology and Applied Pharmacology
Volume115
Issue number2
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Cytotoxicity
Assays
Screening
Fluorescence
Propidium
tert-Butylhydroperoxide
Cells
Cell death
Cell membranes
Hepatocytes
Cultured Cells
Cell Death
Antipain
Aspartic Acid Proteases
Cysteine Proteinase Inhibitors
Quinacrine
Mercuric Chloride
Phospholipases
Poisons
Chlorpromazine

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

A novel cytotoxicity screening assay using a multiwell fluorescence scanner. / Nieminen, Anna Liisa; Gores, Gregory James; Bond, John M.; Imberti, Roberto; Herman, Brian; Lemasters, John J.

In: Toxicology and Applied Pharmacology, Vol. 115, No. 2, 1992, p. 147-155.

Research output: Contribution to journalArticle

Nieminen, Anna Liisa ; Gores, Gregory James ; Bond, John M. ; Imberti, Roberto ; Herman, Brian ; Lemasters, John J. / A novel cytotoxicity screening assay using a multiwell fluorescence scanner. In: Toxicology and Applied Pharmacology. 1992 ; Vol. 115, No. 2. pp. 147-155.
@article{81a04497557e4ea181349649732932da,
title = "A novel cytotoxicity screening assay using a multiwell fluorescence scanner",
abstract = "A new assay using a multiwell fluorescence scanner was developed for screening cytotoxicity to cells cultured in 96-well microtiter plates. The assay is based on binding of propidium iodide to nuclei of cells whose plasma membranes have become permeable due to cell death. Fluorescence of propidium iodide measured with a multiwell fluorescence scanner increased in proportion to the number of permeabilized cells. After ATP depletion of hepatocytes and neonatal cardiac myocytes with metabolic inhibitors ({"}chemical hypoxia{"}), and exposure of Madine Darby canine kidney cells to the toxic chemical, HgCl2, propidium iodide fluorescence progressively increased. Increases of fluorescence were linearly proportional with release of lactate dehydrogenase into the culture medium. Employing this cytotoxicity screening assay, protection by various agents against lethal injury was evaluated in cultured hepatocytes during chemical hypoxia. Inhibitors of cysteine proteases (i.e., antipain, leupeptin, E-64), serine proteases (i.e., PMSF), and aspartic acid proteases (i.e., pepstatin A) did not protect against chemical hypoxia. In contrast, 1,10-phenanthroline, an inhibitor of metalloprotease, markedly protected against the onset of cell death during chemical hypoxia. Half-maximal protection after 60 min occurred at 0.5 μm. Phospholipase inhibitors, chlorpromazine (50 μm) and mepacrine (50 μm), also substantially retarded cell killing. U74006F, an inhibitor of lipid peroxidation, slowed cell killing to a lesser extent during chemical hypoxia and after oxidative stress with t-butyl hydroperoxide. Calciphor, a dimer of prostaglandin B1, did not protect against cell killing during chemical hypoxia or t-butyl hydroperoxide toxicity. In conclusion, this high capacity cytotoxicity assay for cells cultured in 96-well microtiter plates is suitable for rapid screening of potential cytoprotective agents in a variety of cell types.",
author = "Nieminen, {Anna Liisa} and Gores, {Gregory James} and Bond, {John M.} and Roberto Imberti and Brian Herman and Lemasters, {John J.}",
year = "1992",
doi = "10.1016/0041-008X(92)90317-L",
language = "English (US)",
volume = "115",
pages = "147--155",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - A novel cytotoxicity screening assay using a multiwell fluorescence scanner

AU - Nieminen, Anna Liisa

AU - Gores, Gregory James

AU - Bond, John M.

AU - Imberti, Roberto

AU - Herman, Brian

AU - Lemasters, John J.

PY - 1992

Y1 - 1992

N2 - A new assay using a multiwell fluorescence scanner was developed for screening cytotoxicity to cells cultured in 96-well microtiter plates. The assay is based on binding of propidium iodide to nuclei of cells whose plasma membranes have become permeable due to cell death. Fluorescence of propidium iodide measured with a multiwell fluorescence scanner increased in proportion to the number of permeabilized cells. After ATP depletion of hepatocytes and neonatal cardiac myocytes with metabolic inhibitors ("chemical hypoxia"), and exposure of Madine Darby canine kidney cells to the toxic chemical, HgCl2, propidium iodide fluorescence progressively increased. Increases of fluorescence were linearly proportional with release of lactate dehydrogenase into the culture medium. Employing this cytotoxicity screening assay, protection by various agents against lethal injury was evaluated in cultured hepatocytes during chemical hypoxia. Inhibitors of cysteine proteases (i.e., antipain, leupeptin, E-64), serine proteases (i.e., PMSF), and aspartic acid proteases (i.e., pepstatin A) did not protect against chemical hypoxia. In contrast, 1,10-phenanthroline, an inhibitor of metalloprotease, markedly protected against the onset of cell death during chemical hypoxia. Half-maximal protection after 60 min occurred at 0.5 μm. Phospholipase inhibitors, chlorpromazine (50 μm) and mepacrine (50 μm), also substantially retarded cell killing. U74006F, an inhibitor of lipid peroxidation, slowed cell killing to a lesser extent during chemical hypoxia and after oxidative stress with t-butyl hydroperoxide. Calciphor, a dimer of prostaglandin B1, did not protect against cell killing during chemical hypoxia or t-butyl hydroperoxide toxicity. In conclusion, this high capacity cytotoxicity assay for cells cultured in 96-well microtiter plates is suitable for rapid screening of potential cytoprotective agents in a variety of cell types.

AB - A new assay using a multiwell fluorescence scanner was developed for screening cytotoxicity to cells cultured in 96-well microtiter plates. The assay is based on binding of propidium iodide to nuclei of cells whose plasma membranes have become permeable due to cell death. Fluorescence of propidium iodide measured with a multiwell fluorescence scanner increased in proportion to the number of permeabilized cells. After ATP depletion of hepatocytes and neonatal cardiac myocytes with metabolic inhibitors ("chemical hypoxia"), and exposure of Madine Darby canine kidney cells to the toxic chemical, HgCl2, propidium iodide fluorescence progressively increased. Increases of fluorescence were linearly proportional with release of lactate dehydrogenase into the culture medium. Employing this cytotoxicity screening assay, protection by various agents against lethal injury was evaluated in cultured hepatocytes during chemical hypoxia. Inhibitors of cysteine proteases (i.e., antipain, leupeptin, E-64), serine proteases (i.e., PMSF), and aspartic acid proteases (i.e., pepstatin A) did not protect against chemical hypoxia. In contrast, 1,10-phenanthroline, an inhibitor of metalloprotease, markedly protected against the onset of cell death during chemical hypoxia. Half-maximal protection after 60 min occurred at 0.5 μm. Phospholipase inhibitors, chlorpromazine (50 μm) and mepacrine (50 μm), also substantially retarded cell killing. U74006F, an inhibitor of lipid peroxidation, slowed cell killing to a lesser extent during chemical hypoxia and after oxidative stress with t-butyl hydroperoxide. Calciphor, a dimer of prostaglandin B1, did not protect against cell killing during chemical hypoxia or t-butyl hydroperoxide toxicity. In conclusion, this high capacity cytotoxicity assay for cells cultured in 96-well microtiter plates is suitable for rapid screening of potential cytoprotective agents in a variety of cell types.

UR - http://www.scopus.com/inward/record.url?scp=0026718440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026718440&partnerID=8YFLogxK

U2 - 10.1016/0041-008X(92)90317-L

DO - 10.1016/0041-008X(92)90317-L

M3 - Article

C2 - 1641848

AN - SCOPUS:0026718440

VL - 115

SP - 147

EP - 155

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 2

ER -